Spectrum Pharma (SPPI) Says FDA Advisory Committee Votes that Qapzola Has Not Shown Substantial Evidence of Treatment Effect Over Placebo
Go back to Spectrum Pharma (SPPI) Says FDA Advisory Committee Votes that Qapzola Has Not Shown Substantial Evidence of Treatment Effect Over Placebo| Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) | Delayed: 1.03 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.03 | 52 Week High | $7.74 | |||
| Open | $1.03 | 52 Week Low | $3.21 | |||
| Day High | $1.03 | P/E | N/A | |||
| Day Low | $1.03 | EPS | $-0.21 | |||
| Volume | 129,264 | |||||
